Sign in
4

Changes in Ownership

Milestone Pharmaceuticals Inc. Filed Acc 0001209191-19-056625

Options or other derivatives

  • Director acquired 19,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Liebert Debra K. Director 2019-11-12 Grant or award · Stock Option (right to buy) +19,000 19,000 D
Loading xslF345X03/doc4.xml…